Bleichroeder’s Rein Therapeutics RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$804K Hold
1,000,000
– – 0.08% 75
2026
Q2
$1.04M Buy
+1,000,000
New +$1.21M 0.19% 45

Other funds holding RNTX

Bleichroeder's RNTX Position: Q3 2026 in Review

Bleichroeder held its Rein Therapeutics (RNTX) position steady in Q3 2026 at 1,000,000 shares worth $804K. The position accounts for 0.08% of the portfolio, ranked #75.

Bleichroeder first reported a position in RNTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.04M in Q2 2026. 47 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

  • Bleichroeder held 1,000,000 shares of Rein Therapeutics worth $804K as of Q3 2026.
  • Bleichroeder left its Rein Therapeutics share count unchanged in Q3 2026.
  • Rein Therapeutics made up 0.08% of Bleichroeder's portfolio in Q3 2026, its #75 holding.
  • Bleichroeder first reported a position in Rein Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Bleichroeder's Rein Therapeutics position peaked at $1.04M in Q2 2026.
  • 47 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.